...
首页> 外文期刊>Journal of pharmaceutical sciences. >Choice of nonionic surfactant used to formulate type iiia self-emulsifying drug delivery systems and the physicochemical properties of the drug have a pronounced influence on the degree of drug supersaturation that develops during in vitro digestion
【24h】

Choice of nonionic surfactant used to formulate type iiia self-emulsifying drug delivery systems and the physicochemical properties of the drug have a pronounced influence on the degree of drug supersaturation that develops during in vitro digestion

机译:用于配制iiia型自乳化药物递送系统的非离子表面活性剂的选择以及药物的物理化学性质对体外消化过程中产生的药物过饱和度有明显影响

获取原文
获取原文并翻译 | 示例

摘要

The performance of self-emulsifying drug delivery systems (SEDDS) is influenced by their tendency to generate supersaturated systems during dispersion and digestion in the gastrointestinal tract. This study investigated the effect of drug loading on supersaturation during digestion of fenofibrate or danazol SEDDS, each formulated using long-chain lipids and a range of nonionic surfactants. Supersaturation was described by the maximum supersaturation ratio (SRM) produced by in vitro digestion. This parameter was calculated as the ratio of the total concentration of drug present in the digestion vessel versus the drug solubility in the colloidal phases formed by digestion of the SEDDS. SRM proved to be a remarkable indicator of performance across a range of lipid-based formulations. SEDDS containing danazol showed little evidence of precipitation on digestion, even at drug loads approaching saturation in the formulation. In contrast, fenofibrate crystallized extensively on digestion of the corresponding series of SEDDS, depending on the drug loading. The difference was explained by the generation of higher SRM values by fenofibrate formulations. A threshold SRM of 2.5-2.6 was identified in six of the seven SEDDS. This is not a definitive threshold for precipitation, but in general when SRM is greater than 3, fenofibrate supersaturation could not be maintained.
机译:自乳化药物递送系统(SEDDS)的性能受其在胃肠道中分散和消化过程中产生过饱和系统的趋势的影响。这项研究调查了非诺贝特或达那唑SEDDS消化过程中载药量对过饱和的影响,每种药物均使用长链脂质和一系列非离子表面活性剂配制而成。过饱和是通过体外消化产生的最大过饱和比(SRM)来描述的。该参数计算为消化容器中存在的药物总浓度与通过SEDDS消化形成的胶体相中药物溶解度的比率。 SRM被证明是一系列基于脂质的配方中性能的显着指标。含有达那唑的SEDDS在消化时几乎没有沉淀的迹象,即使在药物负荷接近制剂饱和时也是如此。相比之下,非诺贝特在消化相应系列的SEDDS时会大量结晶,具体取决于载药量。非诺贝特制剂产生更高的SRM值可以解释这种差异。在七个SEDDS中的六个中,SRM的阈值为2.5-2.6。这不是确定的沉淀阈值,但是通常在SRM大于3时,不能维持非诺贝特过饱和。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号